Fate Therapeutics Inc.

Fate Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies for patients with cancer and autoimmune diseases. Their focus is on creating off-the-shelf cell therapies, eliminating the need for personalized cell collection and processing. They utilize a proprietary iPSC platform to engineer master iPSC lines, which can be differentiated into immune cells like NK cells and T cells. This enables them to develop a pipeline of product candidates for various indications.

The company aims to address the limitations of existing cell therapies, such as the need for conditioning chemotherapy and the inability to effectively target solid tumors. Their approach involves engineering functionality into master iPSC lines to create highly effective and consistently manufactured cell therapies. They are currently conducting clinical trials for their product candidates, including FT522, an iPSC-derived CAR NK cell therapy, and FT819, an iPSC-derived CAR T-cell therapy for autoimmune diseases. Fate Therapeutics collaborates with leading institutions and pharmaceutical companies, leveraging their expertise to accelerate the development and commercialization of their innovative therapies.

Fate Therapeutics offers flexible work arrangements, including remote work options, to accommodate employees' needs and priorities. This dedication to work-life balance is demonstrated by their commitment to providing a state-of-the-art fitness center on-site, along with generous paid time off and sick leave policies. Additionally, they provide resources and training programs to support employees in their professional development and career growth.

Fate Therapeutics offers a comprehensive benefits package designed to support employee well-being and financial security. Benefits include competitive pay, an annual bonus program, equity awards, a choice of healthcare plans, vision and dental coverage, income protection through life, AD&D and short-term and long-term disability coverage, paid family leave, an employee assistance program, a 401(k) retirement savings plan with company match, generous paid time off and sick leave, and an on-site fitness center to promote employee health and wellness.

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing and bringing to market a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies for patients with cancer and autoimmune diseases. Their mission is to create better cell therapies by utilizing their proprietary iPSC platform to create multiplexed-engineered, clonal master iPSC lines with preferred biological properties. These clonal master iPSC lines serve as a renewable cell source to manufacture cell therapy products that can be delivered off-the-shelf, enabling the treatment of a wider range of patients.

Fate Therapeutics fosters a dynamic and inclusive culture that values intellectual curiosity, resilience, and passion. The company prioritizes employee engagement through various initiatives, including cross-functional events, feedback gathering, and recognizing individual contributions. The "Fate Way" outlines the company's core values and emphasizes collaboration, respect, and a drive to achieve excellence. Fate Therapeutics strives to create an environment that allows employees to contribute meaningfully to the development of groundbreaking cellular immunotherapies for patients.

Fate Therapeutics is committed to building a diverse, equitable, and inclusive workforce, believing that all employees should bring their whole selves to work. They prioritize diversity in their leadership, with women making up 55% of their workforce and 55% of their leadership positions. They invest in employee engagement and development, fostering a collaborative and inclusive culture that values diversity and personal growth.